Delta 9 Cannabis Inc trades with the ticker DN on the TSX and is in the Drug Manufacturers – Specialty & Generic industry.
Overview
Delta 9 Cannabis Inc., together with its subsidiaries, operates as an integrated cannabis company. The company engages in the cultivation, processing, extraction, wholesale distribution, retail, and sale of medical and recreational cannabis products. Its products include dried cannabis flowers, pre-rolls, and dried sift cannabis, as well as oils, and extracted and derivative products. The company also offers grow pods and live plants to other licensed and pre-licensed companies. In addition, it operates as a medical clinic that provides physician consultation services to patients seeking a medical recommendation for a cannabis prescription. The company operates retail stores under the Delta 9 brand name across the Canadian provinces. It also exports its products to Australia. Delta 9 Cannabis Inc. was incorporated in 2001 and is based in Vancouver, Canada.
Looking to invest in Delta 9 Cannabis Inc? Our analysis brings in the key facts, competitor research and valuation metrics for you to make an informed decision.
Table of Contents
show
DN.TO Stock Price and Key Stats
ETF Key Stats
Exchange: TSX
Market Cap : $5.208MM
PE Ratio:
Price: 0.02 (Updated: 3/12/2024 0:47:16)
Delta 9 Cannabis Inc (DN) vs Competitors in Drug Manufacturers – Specialty & Generic
Lets see how DN.TO stacks up against others in the Drug Manufacturers – Specialty & Generic asset management industry. We have identified its main peers as:Aurora Cannabis Inc, Avicanna Inc, Bausch Health Companies Inc, Cardiol Therapeutics Inc, Cronos Group Inc
.Drug Manufacturers – Specialty & Generic Industry Comparisons
| Company | Market Cap ($MM) | P/E Ratio | EV/EBITDA | Dividend Yield |
|---|---|---|---|---|
| Aurora Cannabis Inc (ACB) | $222.521 | N/A | -0.115 | N/A% |
| Avicanna Inc (AVCN) | $43.759 | N/A | -4.217 | N/A% |
| Bausch Health Companies Inc (BHC) | $4,553.034 | N/A | 15.169 | N/A% |
| Cardiol Therapeutics Inc (CRDL) | $132.181 | N/A | -3.0 | N/A% |
| Cronos Group Inc (CRON) | $1,018.068 | N/A | 1.918 | N/A% |
EV/EBITDA: Enterprise Value to Earnings Before Interest, Taxes, Depreciation, and Amortization – this ratio compares the value of a company, including debt, to the company’s cash earnings less non-cash expenses
Industry: companies that have a lot in common
Market Cap: Market Capitalization – the total value of all a corporation’s stock
N/A: Not Applicable or Not Available
P/E: Price-to-Earnings – this ratio relates a corporation’s share price to its earnings per share
Price: Stock Price – current value to buyers and sellers
Dividend Yield: Dividend or Distribution Yield
Comparisons within Drug Manufacturers – Specialty & Generic
- Delta 9 Cannabis Inc (DN) vs Aurora Cannabis Inc (ACB)
- DN has higher EPS (-0.15 vs -79.2). ACB and DN both have P/E’s under 0.
- Delta 9 Cannabis Inc (DN) vs Avicanna Inc (AVCN)
- DN has higher EPS (-0.15 vs -0.17). AVCN and DN both have P/E’s under 0.
- Delta 9 Cannabis Inc (DN) vs Bausch Health Companies Inc (BHC)
- DN has higher EPS (-0.15 vs -2.18). BHC and DN both have P/E’s under 0.
- Delta 9 Cannabis Inc (DN) vs Cardiol Therapeutics Inc (CRDL)
- DN has higher EPS (-0.15 vs -0.43). CRDL and DN both have P/E’s under 0.
- Delta 9 Cannabis Inc (DN) vs Cronos Group Inc (CRON)
- DN has higher EPS (-0.15 vs -0.24). CRON and DN both have P/E’s under 0.
Our Recommendation: Hold
Features a lower EV/EBITDA ratio (-10.99) than the industry average (0.33), indicating attractive valuation.
How to Buy DN stock on the TSX
You can buy on pretty much any online brokerage in Canada, since it trades on the TSX. If you are looking for some easy options take a look at these two:| Image | Product Title | Features | Price |
|---|---|---|---|
Editor's Choice  |
| Get $25 Signup Bonus | |
Reliable Pick  |
| Get $50 Free Stock Trades |
